U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 206143
Company: AMGEN INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CORLANOR IVABRADINE HYDROCHLORIDE EQ 5MG BASE TABLET;ORAL Prescription AB Yes No
CORLANOR IVABRADINE HYDROCHLORIDE EQ 7.5MG BASE TABLET;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/15/2015 ORIG-1 Approval Type 1 - New Molecular Entity PRIORITY Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206143Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206143Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/04/2021 SUPPL-8 Labeling-Container/Carton Labels, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/206143Orig1s008;209964Orig1s002ltr.pdf
05/13/2019 SUPPL-7 Labeling-Medication Guide, Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206143s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206143Orig1s007ltr.pdf
01/10/2017 SUPPL-2 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206143Orig1s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206143Orig1s002ltr.pdf
05/05/2016 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
08/04/2021 SUPPL-8 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf
08/04/2021 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf
05/13/2019 SUPPL-7 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206143s007lbl.pdf
05/13/2019 SUPPL-7 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206143s007lbl.pdf
01/10/2017 SUPPL-2 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206143Orig1s002lbl.pdf
04/15/2015 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf

CORLANOR

TABLET;ORAL; EQ 5MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CORLANOR IVABRADINE HYDROCHLORIDE EQ 5MG BASE TABLET;ORAL Prescription Yes AB 206143 AMGEN INC
IVABRADINE HYDROCHLORIDE IVABRADINE HYDROCHLORIDE EQ 5MG BASE TABLET;ORAL Prescription No AB 213366 ANNORA PHARMA
IVABRADINE HYDROCHLORIDE IVABRADINE HYDROCHLORIDE EQ 5MG BASE TABLET;ORAL Prescription No AB 213442 ZYDUS PHARMS

TABLET;ORAL; EQ 7.5MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CORLANOR IVABRADINE HYDROCHLORIDE EQ 7.5MG BASE TABLET;ORAL Prescription Yes AB 206143 AMGEN INC
IVABRADINE HYDROCHLORIDE IVABRADINE HYDROCHLORIDE EQ 7.5MG BASE TABLET;ORAL Prescription No AB 213366 ANNORA PHARMA
IVABRADINE HYDROCHLORIDE IVABRADINE HYDROCHLORIDE EQ 7.5MG BASE TABLET;ORAL Prescription No AB 213442 ZYDUS PHARMS
Back to Top